Subsequent evaluation of NSUN2 protein levels in 174 clinical samples (131 tumors and 43 paracancerous tissues) from our hospital (SYSU-TFAH cohort) using IHC staining demonstrated predominant expression in the cancer cell nucleus and partial expression in the cytoplasm within HNSCC tissues (Figure 1E). The gene discussed is NSUN2; the disease is cancer.